Rates and Predictors of Nonadherence to the Post-Allogeneic Hematopoietic Cell Transplantation Medical Regimen in Patients and Caregivers.


Journal

Transplantation and cellular therapy
ISSN: 2666-6367
Titre abrégé: Transplant Cell Ther
Pays: United States
ID NLM: 101774629

Informations de publication

Date de publication:
03 2022
Historique:
received: 19 07 2021
revised: 18 11 2021
accepted: 28 11 2021
pubmed: 8 12 2021
medline: 15 4 2022
entrez: 7 12 2021
Statut: ppublish

Résumé

Allogeneic hematopoietic cell transplantation (HCT) requires a complex, multicomponent medical regimen after hospital discharge. Patients must manage multiple medications; care for their catheter; minimize exposure to sources of potential infection; follow diet, exercise, and self-care guidelines; and attend frequent follow-up medical appointments. Their caregivers are tasked with helping them manage the regimen. Despite the importance of this management in preventing adverse clinical outcomes, there has been little study of regimen nonadherence and its predictors. We sought to prospectively determine rates and predictors of nonadherence to components of the post-HCT medical regimen during the first 8 weeks after hospital discharge. Patients (n = 92) and their caregivers (n = 91) (total n = 183) completed interview assessments pre-HCT, and at 4 weeks and 8 weeks after hospital discharge post-HCT. Sociodemographic factors (eg, age, sex), patient clinical status (eg, disease type, donor type), patient and caregiver self-reported health-related factors (eg, medical comorbidities), and patient and caregiver psychosocial factors (eg, anxiety, depression, HCT task-specific and general self-efficacy, relationship quality) were assessed pre-HCT. Nonadherence to each of 17 regimen tasks was assessed at 4 and 8 weeks after hospital discharge via self and caregiver collateral reports. Nonadherence rates varied among tasks, with 11.2% to 15.7% of the sample reporting nonadherence to immunosuppressant medication, 34.8% to 38.6% to other types of medications, 14.6% to 67.4% to required infection precautions, and 27.0% to 68.5% to lifestyle-related behaviors (eg, diet/exercise). Nonadherence rates were generally stable but worsened over time for lifestyle-related behaviors. The most consistent nonadherence predictors were patient and caregiver pre-HCT perceptions of lower HCT task efficacy. Higher caregiver depression, caregiver perceptions of poorer relationship with the patient, having a nonspousal caregiver, and having diseases other than acute myelogenous leukemia also predicted greater nonadherence in 1 or more areas. Rates of nonadherence varied across tasks, and both patient and caregiver factors, particularly self-efficacy, predicted nonadherence. The findings highlight the importance of considering not only patient factors, but also caregiver factors, in post-HCT regimen nonadherence.

Identifiants

pubmed: 34875403
pii: S2666-6367(21)01408-1
doi: 10.1016/j.jtct.2021.11.020
pmc: PMC9004486
mid: NIHMS1762094
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

165.e1-165.e9

Subventions

Organisme : NCI NIH HHS
ID : K23 CA149082
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA047904
Pays : United States

Informations de copyright

Copyright © 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Références

Biol Blood Marrow Transplant. 2020 Aug;26(8):e177-e182
pubmed: 32438042
Cancer. 2020 Dec 15;126(24):5337-5346
pubmed: 33026658
Transplantation. 2008 Jan 27;85(2):193-202
pubmed: 18212623
Biol Blood Marrow Transplant. 2020 Sep;26(9):1627-1634
pubmed: 32505809
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Biol Blood Marrow Transplant. 2020 Jul;26(7):1247-1256
pubmed: 32165328
Bone Marrow Transplant. 2017 Feb;52(2):304-306
pubmed: 27841860
Curr HIV Res. 2019;17(3):161-172
pubmed: 31538899
Bone Marrow Transplant. 2014 Sep;49(9):1223-30
pubmed: 25046214
J Natl Compr Canc Netw. 2020 May 1;18(5):599-634
pubmed: 32519831
Support Care Cancer. 2019 Jun;27(6):2329-2337
pubmed: 30353229
Support Care Cancer. 2019 Feb;27(2):591-600
pubmed: 30022348
Cancer Nurs. 2020 Mar/Apr;43(2):E113-E120
pubmed: 30676398
Psychooncology. 2018 Jan;27(1):354-358
pubmed: 28181721
Health Psychol. 2016 Nov;35(11):1178-1188
pubmed: 27280365
Bone Marrow Transplant. 2005 Jan;35(1):77-83
pubmed: 15502851
J Fam Psychol. 2004 Mar;18(1):184-193
pubmed: 14992620
J Manag Care Pharm. 2009 Nov-Dec;15(9):728-40
pubmed: 19954264
Prog Transplant. 2003 Sep;13(3):183-92
pubmed: 14558632
J Health Soc Behav. 1978 Mar;19(1):2-21
pubmed: 649936
Med Care. 1996 Jan;34(1):73-84
pubmed: 8551813
Expert Rev Clin Immunol. 2019 Jul;15(7):735-751
pubmed: 31070946
Transplantation. 2007 Apr 15;83(7):858-73
pubmed: 17460556
Biol Blood Marrow Transplant. 2017 Apr;23(4):562-568
pubmed: 28087458
J Am Soc Nephrol. 2017 Aug;28(8):2290-2301
pubmed: 28630231
Biol Blood Marrow Transplant. 2003 May;9(5):304-11
pubmed: 12766880
J Gerontol B Psychol Sci Soc Sci. 1999 Jan;54(1):S3-15
pubmed: 9934397
Psychooncology. 2019 Jun;28(6):1252-1260
pubmed: 30942921
Transplantation. 2009 Sep 15;88(5):736-46
pubmed: 19741474
Am J Transplant. 2012 Dec;12(12):3387-97
pubmed: 22958758
Psychol Med. 2004 Aug;34(6):1065-82
pubmed: 15554577
Gen Hosp Psychiatry. 2012 Mar-Apr;34(2):127-38
pubmed: 22245165
BMJ Open. 2021 Sep 2;11(9):e044987
pubmed: 34475141
Biol Blood Marrow Transplant. 2019 Nov;25(11):2222-2227
pubmed: 31247314
Am J Kidney Dis. 2016 Mar;67(3):461-78
pubmed: 26372087
Transl Behav Med. 2015 Dec;5(4):470-82
pubmed: 26622919
Blood Adv. 2018 Apr 24;2(8):909-922
pubmed: 29678809
Curr Hematol Malig Rep. 2017 Aug;12(4):324-334
pubmed: 28573496
PLoS One. 2012;7(12):e50537
pubmed: 23272064
Psychosomatics. 2001 Jul-Aug;42(4):300-13
pubmed: 11496019
Psychooncology. 2019 Sep;28(9):1781-1790
pubmed: 31206917
Med Care. 2004 Mar;42(3):200-9
pubmed: 15076819

Auteurs

Donna M Posluszny (DM)

Department of Medicine, University of Pittsburgh, Pittsburgh, PA; UPMC Hillman Cancer Center, Pittsburgh, PA. Electronic address: poslusznydm@upmc.edu.

Dana H Bovbjerg (DH)

Department of Medicine, University of Pittsburgh, Pittsburgh, PA; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA.

Karen L Syrjala (KL)

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA.

Mounzer Agha (M)

Department of Medicine, University of Pittsburgh, Pittsburgh, PA; UPMC Hillman Cancer Center, Pittsburgh, PA.

Rafic Farah (R)

UPMC Hillman Cancer Center, Pittsburgh, PA.

Jing-Zhou Hou (JZ)

UPMC Hillman Cancer Center, Pittsburgh, PA.

Anastasios Raptis (A)

UPMC Hillman Cancer Center, Pittsburgh, PA.

Annie P Im (AP)

Department of Medicine, University of Pittsburgh, Pittsburgh, PA; UPMC Hillman Cancer Center, Pittsburgh, PA.

Kathleen A Dorritie (KA)

Department of Medicine, University of Pittsburgh, Pittsburgh, PA; UPMC Hillman Cancer Center, Pittsburgh, PA.

Michael M Boyiadzis (MM)

Department of Medicine, University of Pittsburgh, Pittsburgh, PA; UPMC Hillman Cancer Center, Pittsburgh, PA.

Mary Amanda Dew (MA)

Department of Medicine, University of Pittsburgh, Pittsburgh, PA; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH